Clinical Trial Update: HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a) [NA]

View source ↗

Summary

A translational study analyzing tumor samples from patients treated with trastuzumab deruxtecan (T-DXd) to identify biomarkers and predictors of response in met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: SOLTI Breast Cancer Research Group | Conditions: Metastatic Cancer | NA | Status: ACTIVE_NOT_RECRUITING